Apple and Intel weigh in on SCOTUS Arthrex review
Apple and Intel, along with tech and IP groups, are urging the US Supreme Court to retain an administrative process for challenging patents.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Patents
22 June 2021 In a decision highly anticipated by patent owners, the US Supreme Court has delivered its final ruling in US v Arthrex—a fractured opinion that lawyers say leaves burning questions around its political implications.
Patents
30 June 2021 As a result of the recent Supreme Court decision in US v Arthrex, the US Patent and Trademark Office issued new interim procedures on Tuesday, June 29, that give the office’s director the authority to rehear final Patent Trial and Appeal Board rulings.
Patents
5 August 2021 Early signs show that US v Arthrex is unlikely to herald a spate of inter partes reviews, but may fuel uncertainty around the scope of the acting USPTO director’s role, lawyers have told WIPR.